The emerging therapy of tirzepatide peptide represents a major breakthrough in the management of diabetes mellitus type 2. Distinct from existing therapies, tirzepatide affects two pathways – GLP-1 and GIP – https://tirzepatide-peptide901326.aioblogs.com/94738948/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment